ES8701146A1 - Procedimiento para la preparacion de sales del acido d-6 me-toxi-alfametil-2-naftalenacetico - Google Patents

Procedimiento para la preparacion de sales del acido d-6 me-toxi-alfametil-2-naftalenacetico

Info

Publication number
ES8701146A1
ES8701146A1 ES549534A ES549534A ES8701146A1 ES 8701146 A1 ES8701146 A1 ES 8701146A1 ES 549534 A ES549534 A ES 549534A ES 549534 A ES549534 A ES 549534A ES 8701146 A1 ES8701146 A1 ES 8701146A1
Authority
ES
Spain
Prior art keywords
analgesic
preparation
soluble salt
inflammatory activity
pharmaceutical forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES549534A
Other languages
English (en)
Other versions
ES549534A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Biochimico Pavese Pharma SpA
Original Assignee
Istituto Biochimico Pavese Pharma SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Biochimico Pavese Pharma SpA filed Critical Istituto Biochimico Pavese Pharma SpA
Publication of ES8701146A1 publication Critical patent/ES8701146A1/es
Publication of ES549534A0 publication Critical patent/ES549534A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE SALES DEL ACIDO D-6 METOXI-ALFA-METIL-2-NAFTALENACETICO. SE HACE REACCIONAR UNA SOLUCION ACUOSA DE 1-CARBOXI N,NKNL-TRIMETILMETANAMINA SAL SODICA, CON ACIDO D-6 METOXI-ALFA-METIL-2-NAFTALENACETICO DISUELTO EN UN DISOLVENTE ORGANICO SOLUBLE EN AGUA, COMO LA ACETONA. LA REACCION SE REALIZA A UNA TEMPERATURA ENTRE 10 Y 30JC, Y EL PRODUCTO SE CRISTALIZA EN UN EXCESO DE ACETONA. ESTAS SALES SON MUY SOLUBLES EN AGUA Y SON APLICABLES COMO ANTIINFLAMATORIOS Y ANALGESICOS.
ES549534A 1984-12-05 1985-12-03 Procedimiento para la preparacion de sales del acido d-6 me-toxi-alfametil-2-naftalenacetico Expired ES8701146A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23897/84A IT1196356B (it) 1984-12-05 1984-12-05 Sale solubile avente attivita' anti-infiammatoria,procedimento per la sua preparazione e forme farmaceutiche contenenti lo stesso

Publications (2)

Publication Number Publication Date
ES8701146A1 true ES8701146A1 (es) 1986-12-01
ES549534A0 ES549534A0 (es) 1986-12-01

Family

ID=11210728

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549534A Expired ES8701146A1 (es) 1984-12-05 1985-12-03 Procedimiento para la preparacion de sales del acido d-6 me-toxi-alfametil-2-naftalenacetico

Country Status (8)

Country Link
US (1) US4672077A (es)
JP (1) JPS62286956A (es)
BE (1) BE903785A (es)
CH (1) CH663783A5 (es)
DE (1) DE3542906C2 (es)
ES (1) ES8701146A1 (es)
FR (1) FR2574076B1 (es)
IT (1) IT1196356B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL297126A (es) * 1962-08-28

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2794045A (en) * 1953-11-09 1957-05-28 Beaufour Henri Monobetaine citrate
US3002886A (en) * 1958-03-03 1961-10-03 Synergistics Inc Betaine salicylates and the method for their preparation
GB950505A (en) * 1961-01-10 1964-02-26 Mundipharma Ag Improvements in betaine salicylates and the method for their preparation
DE1195767B (de) * 1961-01-10 1965-07-01 Mundipharma Ag Verfahren zur Herstellung eines therapeutisch verwendbaren Salicylsaeuresalzes
FR1391M (fr) * 1961-07-01 1962-07-09 Jacques Emile Cailliot 1-bromo 2-hydroxy 3-naphtoate de bétaine.
US3242048A (en) * 1962-06-20 1966-03-22 Synergistics Inc Betaine glutamate and methods of using same
FR1479304A (fr) * 1966-02-16 1967-05-05 Sapchim Fournier Cimag Soc Nouveaux dérivés aminés de l'acide gentisique et procédés de fabrication
BR6915470D0 (pt) * 1969-03-24 1973-03-13 Syntex Corp Processo para preparar derivados de acido 2-(6'substituido 2'naftil)propionico e de seus sais
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4080472A (en) * 1974-03-22 1978-03-21 Societe D'etudes Et D'exploitation De Marques Et Brevets S.E.M.S. Metformin 2-(p-chlorophenoxy)-2-methylpropionate
DE2935776A1 (de) * 1979-09-05 1981-04-16 Theodor Prof. Dr. 4400 Münster Eckert Organische salze des indometacin, des naproxen und des diclofenac, ihre herstellung und sie enthaltende arzneimittel

Also Published As

Publication number Publication date
JPS62286956A (ja) 1987-12-12
FR2574076B1 (fr) 1989-07-28
CH663783A5 (it) 1988-01-15
BE903785A (fr) 1986-04-01
FR2574076A1 (fr) 1986-06-06
ES549534A0 (es) 1986-12-01
IT1196356B (it) 1988-11-16
US4672077A (en) 1987-06-09
DE3542906C2 (de) 1995-06-14
DE3542906A1 (de) 1986-06-12
IT8423897A0 (it) 1984-12-05

Similar Documents

Publication Publication Date Title
PT77459B (en) Process for the manufacture of novel topically administrable pharmaceutical compositions caontaining a phenyl-alkane-inferior-arboxilic acid or a 2-(2,6-dichloroaniline)-phenylacetic acid or a salt therefrom
AU573938B2 (en) Preparation of glyphosate and derivatives
FI871087A0 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
ES8703460A1 (es) Un procedimiento para preparar aminoacil-ladanos
IE36607B1 (en) A propionamide derivative a method of making it and therapeutic compositions containing it
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
GB1528723A (en) 1-nitro-9-n-substituted aminoalkylamino-acridines their salts and a method of preparing same
ES8701189A1 (es) Procedimiento para preparar derivados s(carbamoil-fenilsele-nicos) de mercaptanos
EP0134582A3 (en) Novel peptides and process for preparing the same and pharmaceutical composition
ES8701146A1 (es) Procedimiento para la preparacion de sales del acido d-6 me-toxi-alfametil-2-naftalenacetico
EP0103320A3 (en) Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them
HUT46292A (en) Process for production of new salts of aryl-oxi-propanol-amines formed by diphenyl acetic acid
ES476266A1 (es) Procedimiento para la preparacion de diaminas ciclicas n,n'-disustituidas.
GB1378068A (en) Citric acid derivatives
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES8507098A1 (es) Procedimiento para la preparacion de l(-)carnitina en forma de cloridrato o en forma de su sal interna.
PT83472A (en) Process for preparing improved antiinflammatory compositions containing piroxicam
ES8502076A1 (es) Procedimiento para la preparacion de acido 3b-(3-carboxipropioniloxi)-ursa-9(11),12-dien-28-oico
LTIP1682A (en) Novel 16,17-acetal-substituted derivatives of pregnan-21-oic acid, process for preparing thereof, pharmaceutical preparations containing them
JPS5557578A (en) Carbamoylpiperazine derivative
ES8706636A1 (es) Un procedimiento para preparar derivados de piridina
DE3572171D1 (en) Theophylline-7-acetic acid ester of d,l-trans-sobrerol having mucosecretolytic-fluidizing and antibronchospastic activity, a process for its preparation and pharmaceutical compositions thereof
AU562271B2 (en) Pharmaceutical composition of corazepam and diphenhydramine
JPS57106644A (en) Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation
JPS51115402A (en) Process for preparation of alpha-amino acid